Nathalie Dubois-Stringfellow - SVP-CHIEF DEVELOPMENT OFFICER at Sangamo Therapeutics, Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Svp Chief Development Officer
Stock Symbol
SGMO on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Nathalie Dubois-Stringfellow since 9/17/2023

Holdings reported by Nathalie Dubois-Stringfellow for Sangamo Therapeutics, Inc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 845K $726K $0.86 Aug 25, 2024 Direct

Transactions reported by Nathalie Dubois-Stringfellow for Sangamo Therapeutics, Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.